Octapharma Uses IVIG as Potential Treatment for COVID-19

Octapharma Uses IVIG as Potential Treatment for COVID-19

Source: 
BioSpace
snippet: 

Intravenous immunoglobulin (IVIG) could be a key to combating seriously ill COVID-19 patients who have been hospitalized due to complications from the disease, and Octapharma AG aims to find out as it assesses the plasma-based treatment in a Phase III study.